BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 29032999)

  • 1. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
    Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
    Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.
    Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Santana C; Ospina J; Lara PC
    Clin Transl Oncol; 2021 Jan; 23(1):179-182. PubMed ID: 32445034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
    Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
    Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
    Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
    Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated.
    Veronesi U; Orecchia R; Luini A; Gatti G; Intra M; Zurrida S; Ivaldi G; Tosi G; Ciocca M; Tosoni A; De Lucia F
    Eur J Cancer; 2001 Nov; 37(17):2178-83. PubMed ID: 11677104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
    Reitsamer R; Peintinger F; Sedlmayer F; Kopp M; Menzel C; Cimpoca W; Glueck S; Rahim H; Kopp P; Deutschmann H; Merz F; Brandis M; Kogelnik H
    Eur J Cancer; 2002 Aug; 38(12):1607-10. PubMed ID: 12142049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
    Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
    Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand].
    Gatzemeier W; Orecchia R; Gatti G; Intra M; Veronesi U
    Strahlenther Onkol; 2001 Jul; 177(7):330-7. PubMed ID: 11505618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients.
    Jacobs DHM; Speijer G; Petoukhova AL; Roeloffzen EMA; Straver M; Marinelli A; Fisscher U; Zwanenburg AG; Merkus J; Marijnen CAM; Mast ME; Koper PCM
    Breast Cancer Res Treat; 2018 Jun; 169(3):549-559. PubMed ID: 29460031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.